Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Current Leases (2022 - 2025)

Rani Therapeutics Holdings (RANI) has 4 years of Current Leases data on record, last reported at $1.0 million in Q3 2025.

  • For Q3 2025, Current Leases fell 25.6% year-over-year to $1.0 million; the TTM value through Sep 2025 reached $1.0 million, down 25.6%, while the annual FY2024 figure was $1.5 million, 103.2% up from the prior year.
  • Current Leases reached $1.0 million in Q3 2025 per RANI's latest filing, down from $1.2 million in the prior quarter.
  • Across five years, Current Leases topped out at $1.5 million in Q4 2024 and bottomed at $658000.0 in Q2 2022.
  • Average Current Leases over 4 years is $1.1 million, with a median of $1.0 million recorded in 2022.
  • Peak YoY movement for Current Leases: dropped 28.63% in 2023, then skyrocketed 103.2% in 2024.
  • A 4-year view of Current Leases shows it stood at $1.0 million in 2022, then decreased by 28.63% to $718000.0 in 2023, then surged by 103.2% to $1.5 million in 2024, then fell by 28.1% to $1.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Leases were $1.0 million in Q3 2025, $1.2 million in Q2 2025, and $1.3 million in Q1 2025.